Pharmacokinetics and Bioavailability of Intravenous, Intramuscular, and Oral Lorazepam in Humans
The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Lorazepam | Glucuronidation (24) | NA | 7-26 (39, 40) | NA”
From Benzodiazepines in epilepsy: Pharmacology and pharmacokinetics (2008) · cites this paper as [39]
Citations
Cites
An Algorithm for Least-Squares Estimation of Nonlinear Parameters
Marquardt, D. W. (1963) · Journal of the Society for Industrial and Applied Mathematics · doi:10.1137/0111030 · Cited by 30,728
SNEDECOR, G. W. (1939) · Soil Science · doi:10.1097/00010694-193902000-00006 · Cited by 19,359
A physiological approach to hepatic drug clearance
Wilkinson, G. R., & Shand, D. G. (1975) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1975184377 · Cited by 1,873
Fundamentals of Clinical Pharmacokinetics
Wagner, J. G. (1975) · Medical Entomology and Zoology · Cited by 1,041
Statistical estimations in pharmacokinetics
Boxenbaum, H. G., Riegelman, S., & Elashoff, R. M. (1974) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf01061504 · Cited by 721
Fundamentals of clinical pharmacokinetics
Crouthamel, W. G. (1976) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600650639 · Cited by 668
Wagner, J. G. (1976) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf01062831 · Cited by 341
Benzodiazepines in Clinical Practice
Shader, R. I., & Greenblatt, D. J. (1974) · Cited by 308
Self-citationAssessment of Pharmacokinetic Constants from Postinfusion Blood Curves Obtained after I.V. Infusion
Loo, J. C. K., & Riegelman, S. (1970) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600590107 · Cited by 301
Psychopharmacology: A Generation of Progress
Krueger, A. L. (1978) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1978.03290130112040 · Cited by 291
Research works printed but not linked: 14
- Greenblatt, 1977, J. Pharmacol. Exp. Ther., 202, 365
- Comer, 1973, J. Int. Med. Res., 1, 216
- Blitt, 1976, Anesth. Analg. (Cleveland), 55, 522
- Gomez-Lozano, 1976, Curr. Ther. Res. Clin. Exp., 19, 469
- Schillings, 1971, Arzneim-Forsch., 21, 1059
- Knowles, 1971, Arzneim-Forsch., 21, 1055
- Dundee, 1976, Acta Anaesthesiol. Belg., 27, 3
- Aleniewski, 1977, Anesth. Anoig. (Cleveland), 56, 489
- Mundeleer, 1976, Acta Anaesthesiol. Belg., 27, 12
- Fragen, 1976, Anesth. Analg. (Cleveland), 55, 795
- Verschraegen, 1974, Acta Anaesthesiol. Belg., 25, 68
- Knapp, 1974, Anesth. Analg. (Cleveland), 53, 122
- Kanto, 1975, Int. J. Clin. Pharmacol., 12, 427
- Palestine, 1976, Curr. Ther. Res. Clin. Exp., 20, 289
Cited by
Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017
Hiemke, C., Bergemann, N., Clement, H., Conca, A., Deckert, J., Domschke, K., Eckermann, G., Egberts, K., Gerlach, M., Greiner, C., et al. (2018) · Pharmacopsychiatry · doi:10.1055/s-0043-116492 · Cited by 1,446
AGNP Consensus Guidelines for Therapeutic Drug Monitoring in Psychiatry: Update 2011
Hiemke, C., Baumann, P., Bergemann, N., Conca, A., Dietmaier, O., Egberts, K., Fric, M., Gerlach, M., Greiner, C., Gründer, G., et al. (2011) · Pharmacopsychiatry · doi:10.1055/s-0031-1286287 · Cited by 868
Greenblatt (1982) · doi:10.1056/nejm198205063061804 · Cited by 584
Benzodiazepines in epilepsy: Pharmacology and pharmacokinetics
Riss, J., Cloyd, J., Gates, J., & Collins, S. (2008) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2008.01004.x · Cited by 511
Midazolam and Other Benzodiazepines
Olkkola, K. T., & Ahonen, J. (2008) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-540-74806-9_16 · Cited by 488
“been identified. The mean elimination half-time is 15 h with a range of 8–25 h ( Greenblatt et al. 1979 ).”
BackgroundInfluentialCurrent Status of Benzodiazepines
Koch-Weser, J., Greenblatt, D. J., Shader, R. I., & Abernethy, D. R. (1983) · New England Journal of Medicine · doi:10.1056/nejm198308183090705 · Cited by 451
Self-citationManagement of Alcohol Withdrawal Delirium<subtitle>An Evidence-Based Practice Guideline</subtitle>
Mayo-Smith, M. F. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.13.1405 · Cited by 418
GABAergic modulation of DC stimulation‐induced motor cortex excitability shifts in humans
Nitsche, M. A., Liebetanz, D., Schlitterlau, A., Henschke, U., Fricke, K., Frommann, K., Lang, N., Henning, S., Paulus, W., & Tergau, F. (2004) · European Journal of Neuroscience · doi:10.1111/j.0953-816x.2004.03398.x · Cited by 371
Clinical Pharmacokinetics of Oxazepam and Lorazepam
Greenblatt, D. J. (1981) · Clinical Pharmacokinetics · doi:10.2165/00003088-198106020-00001 · Cited by 367
Self-citationDouble-blind study of lorazepam and diazepam in status epilepticus
Leppik, L. E. (1983) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1983.03330350028021 · Cited by 354
Diazepam disposition determinants
Greenblatt, D. J., Allen, M. D., Harmatz, J. S., & Shader, R. I. (1980) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1980.40 · Cited by 348
Self-citationPharmacokinetic Optimisation of Benzodiazepine Therapy for Acute Seizures: Focus on Delivery Routes
Rey, E., Tr??luyer, J.-M., & Pons, G. (1999) · Clinical Pharmacokinetics · doi:10.2165/00003088-199936060-00003 · Cited by 265
Pharmacological Management of Acute Agitation
Battaglia, J. (2005) · Drugs · doi:10.2165/00003495-200565090-00003 · Cited by 254
Propofol vs Midazolam in Short-, Medium-, and Long-term Sedation of Critically III Patients
Carrasco, G., Molina, R., Costa, J., Soler, J.-M., & Cabré, L. (1993) · Chest · doi:10.1378/chest.103.2.557 · Cited by 251
Current Status of Benzodiazepines
Koch-Weser, J., Greenblatt, D. J., Shader, R. I., & Abernethy, D. R. (1983) · New England Journal of Medicine · doi:10.1056/nejm198308113090607 · Cited by 249
Self-citationChanges in Gastric Emptying Rates with Age
Horowitz, M., Maddern, G. J., Chatterton, B. E., Collins, P. J., Harding, P. E., & Shearman, D. J. C. (1984) · Clinical Science · doi:10.1042/cs0670213 · Cited by 217
Barr, J., Zomorodi, K., Bertaccini, E. J., Shafer, S. L., & Geller, E. (2001) · Anesthesiology · doi:10.1097/00000542-200108000-00007 · Cited by 209
Benzodiazepines: a summary of pharmacokinetic properties.
Greenblatt, D., Shader, R., Divoll, M., & Harmatz, J. (1981) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1981.tb01833.x · Cited by 190
Self-citationIs Chlordiazepoxide the Rational Choice Among Benzodiazepines?
Baskin, S. I., & Esdale, A. (1982) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1982.tb03181.x · Cited by 174
Nicolas, J., Hannestad, J., Holden, D., Kervyn, S., Nabulsi, N., Tytgat, D., Huang, Y., Chanteux, H., Staelens, L., Matagne, A., et al. (2016) · Epilepsia · doi:10.1111/epi.13267 · Cited by 169
Effect of age and gender on disposition of temazepam
Divoll, M., Greenblatt, D. J., Harmatz, J. S., & Shader, R. I. (1981) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600701004 · Cited by 167
Self-citationPharmacological Significance of Synthetic Heterocycles Scaffold: A Review
Dua, R., & Shrivastava, S. (2011) · Cited by 264
Saari, T. I., Uusi‐Oukari, M., Ahonen, J., & Olkkola, K. T. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.002717 · Cited by 170
Abduljalil, K., Cain, T., Humphries, H., & Rostami‐Hodjegan, A. (2014) · Drug Metabolism and Disposition · doi:10.1124/dmd.114.058099 · Cited by 158
Greenblatt, D. J., Divoll, M., Harmatz, J. S., & Shader, R. I. (1982) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600710227 · Cited by 134
Self-citationOptimal Intravenous Dosing Strategies for Sedatives and Analgesics in the Intensive Care Unit
Barr, J., & DONNER, A. (1995) · Critical Care Clinics · doi:10.1016/s0749-0704(18)30041-1 · Cited by 139
Maharaj, A. R., Barrett, J. S., & Edginton, A. N. (2013) · The AAPS Journal · doi:10.1208/s12248-013-9451-0 · Cited by 128
Pharmacokinetics and pharmacodynamics of alprazolam after oral and IV administration
Smith, R. B., Kroboth, P. D., VanderLugt, J. T., Phillips, J. P., & Juhl, R. P. (1984) · Psychopharmacology · doi:10.1007/bf00431449 · Cited by 126
Wermeling, D. P. H., Miller, J. L., Archer, S. M., Manaligod, J. M., & Rudy, A. C. (2001) · The Journal of Clinical Pharmacology · doi:10.1177/00912700122012779 · Cited by 112
Clinical Pharmacokinetics of Non-Opiate Abused Drugs
Busto, U., Bendayan, R., & Sellers, E. M. (1989) · Clinical Pharmacokinetics · doi:10.2165/00003088-198916010-00001 · Cited by 126
Blyden, G. T., Greenblatt, D. J., Scavone, J. M., & Shader, R. I. (1986) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1986.tb02946.x · Cited by 98
Self-citationPharmacologic treatment of status epilepticus
Trinka, E., Höfler, J., Leitinger, M., Rohracher, A., Kalss, G., & Brigo, F. (2015) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2016.1127354 · Cited by 103
Ameer, B., Greenblatt, D. J., Divoll, M., Abernethy, D. R., & Shargel, L. (1981) · Journal of Chromatography B Biomedical Sciences and Applications · doi:10.1016/s0378-4347(00)84226-7 · Cited by 93
Self-citationReduced clearance of triazolam in old age: relation to antipyrine oxidizing capacity.
Greenblatt, D., Divoll, M., Abernethy, D., Moschitto, L., Smith, R., & Shader, R. (1983) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1983.tb01503.x · Cited by 92
Self-citationClinical Pharmacokinetics of Sedatives in Neonates
Jacqz-Aigrain, É., & Burtin, P. (1996) · Clinical Pharmacokinetics · doi:10.2165/00003088-199631060-00003 · Cited by 94
Postoperative Analgesia and Sedation in the Adult Intensive Care Unit
Liu, L. L., & Gropper, M. A. (2003) · Drugs · doi:10.2165/00003495-200363080-00003 · Cited by 89
Rapid tranquillisation: Time for a reappraisal of options for parenteral therapy
McAllister-Williams, H., & Ferrier, I. N. (2002) · The British Journal of Psychiatry · doi:10.1192/bjp.180.6.485 · Cited by 94
“Consequently, intramuscular lorazepam, which is better absorbed (Greenblatt et al, 1979), is the benzodiazepine of choice (Atakan & Davies, 1997; Kerr & Taylor, 1997).”
BackgroundAmeer, B., & Greenblatt, D. J. (1981) · Drugs · doi:10.2165/00003495-198121030-00001 · Cited by 88
Self-citationDiazepam in the Treatment of Moderate to Severe Alcohol Withdrawal
Weintraub, S. J. (2017) · CNS Drugs · doi:10.1007/s40263-016-0403-y · Cited by 96
The Treatment of Alcohol Withdrawal
Guthrie, S. K. (1989) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1989.tb04119.x · Cited by 86
Use of intramuscular midazolam for status epilepticus
Towne, A. R., & DeLorenzo, R. J. (1999) · Journal of Emergency Medicine · doi:10.1016/s0736-4679(98)00170-x · Cited by 83
Swart, E. L., Zuideveld, K. P., DeJongh, J., Danhof, M., THIJS, L. G., & van Schijndel, R. J. M. S. (2003) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2003.01957.x · Cited by 82
Clinical Pharmacology Studies in Critically Ill Children
Thakkar, N., Salerno, S. N., Hornik, C. P. V., & González, D. (2016) · Pharmaceutical Research · doi:10.1007/s11095-016-2033-y · Cited by 85
Rapid tranquilization of the violent patient
Dubin, W. R., & Feld, J. A. (1989) · The American Journal of Emergency Medicine · doi:10.1016/0735-6757(89)90179-4 · Cited by 72
A double-blind comparison of lorazepam and oxazepam in psychomotor retardation and mutism
Schmider, J., Standhart, H., Deuschle, M., Drancoli, J., & Heuser, I. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00312-6 · Cited by 75
Pharmacokinetics of lorazepam in critically ill neonates with seizures
McDERMOTT, C., Kowalczyk, A. L., Schnitzler, E. R., Mangurten, H. H., Rodvold, K. A., & Metrick, S. (1992) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)80925-4 · Cited by 66
Snellen, F. F., Lauwers, P., Derneyere, R., Byttebier, G., & Aken, H. V. (1990) · Intensive Care Medicine · doi:10.1007/bf01706356 · Cited by 66
“Benzodiazepines like diazepam or lorazepam show a slow onset and long duration of action with acitve metabolites [21, 22 ].”
BackgroundUncertainty factors for chemical risk assessment: interspecies differences in glucuronidation
Walton, K., Dorne, J. L. C. M., & RENWICK, A. G. (2001) · Food and Chemical Toxicology · doi:10.1016/s0278-6915(01)00088-6 · Cited by 60
Effect of age and sex on disposition of desmethyldiazepam formed from its precursor clorazepate
Shader, R. I., Greenblatt, D. J., Ciraulo, D. A., Divoll, M., Harmatz, J. S., & Georgotas, A. (1981) · Psychopharmacology · doi:10.1007/bf00432186 · Cited by 60
Self-citationPhysical and Chemical Restraints
Coburn, V. A., & Mycyk, M. B. (2009) · Emergency Medicine Clinics of North America · doi:10.1016/j.emc.2009.07.003 · Cited by 59
VIOLENT PATIENTS IN THE EMERGENCY SETTING
Citrome, L., & Volavka, J. (1999) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(05)70126-x · Cited by 59
Lorazepam and midazolam in the intensive care unit
Cernaianu, A. C., DelRossi, A. J., Flum, D. R., Vassilidze, T. V., Ross, S. E., Cilley, J., GROSSO, M. A., & Boysen, P. G. (1996) · Critical Care Medicine · doi:10.1097/00003246-199602000-00007 · Cited by 57
Swart, E. L., DeJongh, J., Zuideveld, K. P., Danhof, M., THIJS, L. G., & van Schijndel, R. J. M. S. (2005) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2004.09.004 · Cited by 56
Central Nervous System Depressants
Schuckit, M. A. (2000) · Springer eBooks · doi:10.1007/978-1-4757-3232-0_2 · Cited by 53
Age Does Not Alter Acetaminophen Absorption
DIVOLL, M., AMEER, B., ABERNETHY, D. R., & GREENBLATT, D. J. (1982) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1982.tb07093.x · Cited by 53
Self-citationOxaprozin pharmacokinetics in the elderly.
Greenblatt, D. J., Matlis, R., Scavone, J. M., Blyden, G. T., Harmatz, J. S., & Shader, R. I. (1985) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1985.tb02656.x · Cited by 54
Self-citationPharmacological Management of Acute and Persistent Aggression in Forensic Psychiatry Settings
Citrome, L., & Volavka, J. (2011) · CNS Drugs · doi:10.2165/11596930-000000000-00000 · Cited by 54
Management of the Violent Patient
Rice, M., & Moore, G. P. (1991) · Emergency Medicine Clinics of North America · doi:10.1016/s0733-8627(20)30202-9 · Cited by 51
Validation of a pre‐anaesthetic screening questionnaire
Hilditch, W. G., Asbury, A. J., Jack, E. S., & McGrane, S. (2003) · Anaesthesia · doi:10.1046/j.1365-2044.2003.03335.x · Cited by 53
Goucher, E., Kicman, A. T., Smith, N. W., & Jickells, S. M. (2009) · Journal of Separation Science · doi:10.1002/jssc.200900097 · Cited by 48
Almohaish, S., Sandler, M., & Brophy, G. M. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10081754 · Cited by 52
Benzodiazepines in panic disorder and agoraphobia
Sheehan, D. V. (1987) · Journal of Affective Disorders · doi:10.1016/0165-0327(87)90021-8 · Cited by 48
Lorazepam in the Treatment of Refractory Neonatal Seizures: A Pilot Study
Deshmukh, A., Wittert, W., Schnitzler, E., & Mangurten, H. H. (1986) · American journal of diseases of children · doi:10.1001/archpedi.1986.02140240088032 · Cited by 47
Interaction of propoxyphene with diazepam, alprazolam and lorazepam.
Abernethy, D., Greenblatt, D. J., Morse, D. S., & Shader, R. I. (1985) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1985.tb02612.x · Cited by 47
Self-citationClobazam Kinetics: Intrasubject Variability and Effect of Food on Absorption
Divoll, M., Greenblatt, D. J., Ciraulo, D. A., Puri, S. K., Ho, I., & Shader, R. I. (1982) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1982.tb05711.x · Cited by 45
Self-citationIntravenous Benzodiazepines as Anaesthetic Agents: Pharmacokinetics and Clinical Consequences
Kanto, J., & Klotz, U. E. (1982) · Acta Anaesthesiologica Scandinavica · doi:10.1111/j.1399-6576.1982.tb01817.x · Cited by 45
Enhanced hepatic drug clearance in patients with cystic fibrosis
Kearns, G. L., Mallory, G. B., Crom, W. R., & Evans, W. E. (1990) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)80149-0 · Cited by 44
Disposition of oxazepam in relation to age, sex, and cigarette smoking
Ochs, H., Greenblatt, D. J., & Otten, H. (1981) · Journal of Molecular Medicine · doi:10.1007/bf01721923 · Cited by 44
Self-citationGupta, S. K., Ellinwood, E. H., Nikaido, A. M., & Heatherly, D. G. (1990) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf01063553 · Cited by 43
“and t-lag represent fast absorption of lorazepam from solution formulation compared to previously reported parameter values in which a solid dosage form (tablet) was used (8).”
ResultSingle- and multiple-dose kinetics of oral lorazepam in humans: The predictability of accumulation
Greenblatt, D. J., ALLEN, M. D., MacLaughlin, D. S., Huffman, D. H., Harmatz, J. S., & Shader, R. I. (1979) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf01059736 · Cited by 42
Self-citationInfluence of age, gender, and obesity on salicylate kinetics following single doses of aspirin
Greenblatt, D. J., Abernethy, D. R., Boxenbaum, H. G., Matlis, R., Ochs, H. R., Harmatz, J. S., & Shader, R. I. (1986) · Arthritis & Rheumatism · doi:10.1002/art.1780290805 · Cited by 42
Self-citationPsychopharmacology and the Management of Violent Patients
Brizer, D. A. (1988) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(18)30469-6 · Cited by 46
Citrome, L. (2004) · Psychiatric Quarterly · doi:10.1023/b:psaq.0000031791.53142.85 · Cited by 38
Metronidazole Impairs Clearance of Phenytoin but Not of Alprazolam or Lorazepam
Blyden, G. T., Scavone, J. M., & Greenblatt, D. J. (1988) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1988.tb03139.x · Cited by 38
Self-citationHerman, R. A., & Veng‐Pedersen, P. (1994) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600830332 · Cited by 38
Single- and multiple-dose kinetics of estazolam, a triazolo benzodiazepine
ALLEN, M. D., Greenblatt, D. J., & Arnold, J. D. (1979) · Psychopharmacology · doi:10.1007/bf00428318 · Cited by 37
Self-citationBerton, M., Bettonte, S., Stader, F., Battegay, M., & Marzolini, C. (2022) · Clinical Pharmacokinetics · doi:10.1007/s40262-022-01194-3 · Cited by 36
Jack, M. L., Colburn, W. A., Spirt, N. M., Bautz, G., Zanko, M. T., Horst, W. D., & O'Brien, R. A. (1983) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(83)90036-2 · Cited by 36
Veng‐Pedersen, P., & Gillespie, W. R. (1986) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600751202 · Cited by 35
Interaction of Diazepam With Famotidine and Cimetidine, Two H2‐Receptor Antagonists
Locniskar, A., Greenblatt, D. J., Harmatz, J. S., Zinny, M. A., & Shader, R. I. (1986) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1986.tb03527.x · Cited by 34
Self-citationPhysiologic Changes in Old Age: Relation to Altered Drug Disposition
Greenblatt, D. J., Divoll, M., Abernethy, D. R., & Shader, R. I. (1982) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1982.tb01350.x · Cited by 37
Self-citationPharmacology of Intravenous Sedatives and Opioids in Critically Ill Patients
Levine, R. L. (1994) · Critical Care Clinics · doi:10.1016/s0749-0704(18)30102-7 · Cited by 34
Pesic, M., Stöhr, T., Ossig, J., Borkett, K., Donsbach, M., Dao, V.-A., Webster, L., & Schippers, F. (2020) · Drugs in R&D · doi:10.1007/s40268-020-00317-0 · Cited by 30
Erstad, B. L., & Barletta, J. F. (2022) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/zxac058 · Cited by 37
Gillespie, W. R., & Veng‐Pedersen, P. (1985) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf01061479 · Cited by 32
“9-217 Lorazepam (21, 22) 17 2-4 243 • 257 4.”
BackgroundTherapeutic Considerations in the Management of Agitated or Delirious Critically 111 Patients
Hassan, E., Fontaine, D. K., & Nearman, H. S. (1998) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1998.tb03831.x · Cited by 32
Benzodiazepine pharmacodynamics: evidence for biophase rate limiting mechanisms
Ellinwood, E. H., Nikaido, A. M., Heatherly, D. G., & Bjornsson, T. D. (1987) · Psychopharmacology · doi:10.1007/bf00217057 · Cited by 32
The effects of concurrent atorvastatin therapy on the pharmacokinetics of intravenous midazolam
Donnell, C. G. M., Harte, S. E., O'Driscoll, J. G., OLOUGHLIN, C., Pelt, F. D. V., & Shorten, G. D. (2003) · Anaesthesia · doi:10.1046/j.1365-2044.2003.03339.x · Cited by 31
Pharmacokinetics of brotizolam in healthy subjects following intravenous and oral administration.
Jochemsen, R., Wesselman, J., Hermans, J., van Boxtel, C. J., & Breimer, D. D. (1983) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1983.tb02302.x · Cited by 31
Effect on postural sway of various benzodiazepine tranquillizers.
Patat, A. A., & Foulhoux, P. (1985) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1985.tb02792.x · Cited by 30
Intramuscular and rectal therapies of acute seizures
Leppik, I. E., & Patel, S. (2015) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2015.05.001 · Cited by 29
Long‐Term Comparison of Alprazolam, Lorazepam and Placebo in Patients with an Anxiety Disorder
Cohn, J. B., & Wilcox, C. S. (1984) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1984.tb03327.x · Cited by 28
Intravenous and Intramuscular Formulations of Antiseizure Drugs in the Treatment of Epilepsy
Patel, S., Birnbaum, A. K., Cloyd, J. C., & Leppik, I. E. (2015) · CNS Drugs · doi:10.1007/s40263-015-0289-0 · Cited by 30
A simplex procedure for fitting nonlinear pharmacokinetic models
Harmatz, J. S., & Greenblatt, D. J. (1987) · Computers in Biology and Medicine · doi:10.1016/0010-4825(87)90044-8 · Cited by 27
Self-citationGangurde, P. K., Bhaskaran, N. A., & Kumar, L. (2018) · Journal of Pharmaceutical Innovation · doi:10.1007/s12247-018-9343-z · Cited by 27
Connemann, B. J., Mann, K., Lange‐Asschenfeldt, C., Ruchsow, M., Schreckenberger, M., Bartenstein, P., & Gründer, G. (2005) · Clinical Neurophysiology · doi:10.1016/j.clinph.2004.11.015 · Cited by 26
Design and Evaluation of a Lorazepam Transdermal Delivery System
Costa, P. C., Ferreira, D., Morgado, R., & Lobo, J. M. S. (1997) · Drug Development and Industrial Pharmacy · doi:10.3109/03639049709149144 · Cited by 26
Pharmacokinetics of two lorazepam formulations, oral and sublingual, after multiple doses
Caillé, G., Spénard, J., Lacasse, Y., & Brennan, J. M. (1983) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.2510040106 · Cited by 25
Veng‐Pedersen, P., & Gillespie, W. R. (1987) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf01066323 · Cited by 25
Comparative pharmacokinetics of alprazolam and lorazepam in humans and in African Green Monkeys
Friedman, H., Redmond, D. E., & Greenblatt, D. J. (1991) · Psychopharmacology · doi:10.1007/bf02244562 · Cited by 24
Self-citation
Metadata
- Authors
- Greenblatt, D. J., Shader, R. I., Franke, K., MacLaughlin, D. S., Harmatz, J. S., Allen, M. D., Werner, A., & Woo, E.
- Affiliations
- Massachusetts General Hospital (US)
- Massachusetts Mental Health Center (US)
- Corresponding author
- Greenblatt, David J.
- Venue
- Journal of Pharmaceutical Sciences
- Publisher
- Elsevier BV
- Published
- 1979-01
- Volume
- 68
- Issue
- 1
- Pages
- 57-63
- ISSN
- 0022-3549 (ISSN-L)
- OpenAlex
- W2131225731
- Cited by
- 197
- References
- 49
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 1 · 2023: 2 · 2022: 3 · 2021: 4 · 2020: 3 · 2019: 1 · 2018: 1 · 2017: 4 · 2016: 4 · 2015: 7 · 2014: 4 · 2013: 3
- FWCI
- 11.52
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Journal of Pharmaceutical Sciences (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Anesthesia and Sedative Agents
- Health Sciences › Medicine › Pharmacology (medical) › Antibiotics Pharmacokinetics and Efficacy
- Keywords
- lorazepam, pharmacokinetics, bioavailability, intramuscular injection, oral administration, intravenous infusion, urinary excretion, absorption kinetics, volume of distribution, elimination half-life, benzodiazepines
- MeSH terms
- Administration, Oral, Adult, Biological Availability, Female, Half-Life, Humans, Infusions, Parenteral, Injections, Intramuscular, Kinetics, Lorazepam, Male, Models, Biological, Anti-Anxiety Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.